Literature DB >> 27455894

Nocturia: aetiology and treatment in adults.

Hasan Dani1, Ashanda Esdaille1, Jeffrey P Weiss1.   

Abstract

Nocturia is an extremely common condition that has major sequelae for affected patients. Through disruption of sleep, nocturia impairs quality of life and worsens health outcomes, and is associated with a variety of morbidities including diabetes, coronary artery disease, obstructive sleep apnoea, obesity, metabolic syndrome, and depression. Unsurprisingly, several studies have also linked nocturia with reduced survival. Nocturia is not simply a consequence of lower urinary tract disease; rather, it is a multifactorial disorder that is often a manifestation of an underlying renal or systemic disease. Through the use of the frequency volume chart, clinicians can accurately quantify nocturia and determine its aetiology. Evaluation of quality of life and sleep using simple measures is essential in order to assess the impact of nocturia on a patient. Numerous treatment options for nocturia exist, but most are associated with minor benefit or lack sufficient evidence supporting their use. By systematically analysing an individual's causes of nocturia, clinicians can design appropriate treatment strategies to most effectively treat this condition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27455894     DOI: 10.1038/nrurol.2016.134

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  134 in total

Review 1.  Regulation and dysregulation of aquaporins in water balance disorders.

Authors:  S Nielsen; T-H Kwon; J Frøkiaer; P Agre
Journal:  J Intern Med       Date:  2007-01       Impact factor: 8.989

2.  Quantitative association between nocturnal voiding frequency and objective sleep quality in the general elderly population: the HEIJO-KYO cohort.

Authors:  Kenji Obayashi; Keigo Saeki; Norio Kurumatani
Journal:  Sleep Med       Date:  2015-03-23       Impact factor: 3.492

3.  Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies.

Authors:  Andreas Eisenhardt; Tim Schneider; Francisco Cruz; Matthias Oelke
Journal:  World J Urol       Date:  2014-01-18       Impact factor: 4.226

4.  Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies.

Authors:  Matthias Oelke; Claus G Roehrborn; Carlos D'Ancona; Timothy H Wilson; Ramiro Castro; Michael Manyak
Journal:  World J Urol       Date:  2014-06-06       Impact factor: 4.226

5.  Effect of combined systematized behavioral modification education program with desmopressin in patients with nocturia: a prospective, multicenter, randomized, and parallel study.

Authors:  Sung Yong Cho; Kyu-Sung Lee; Jang Hwan Kim; Ju Tae Seo; Myung-Soo Choo; Joon Chul Kim; Jong Bo Choi; Miho Song; Ji-Youn Chun; Seung-June Oh
Journal:  Int Neurourol J       Date:  2014-12-29       Impact factor: 2.835

Review 6.  Pygeum africanum for benign prostatic hyperplasia.

Authors:  T Wilt; A Ishani; R Mac Donald; I Rutks; G Stark
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency.

Authors:  Jeffrey P Weiss; Zhanna Jumadilova; Theodore M Johnson; Mary P Fitzgerald; Martin Carlsson; Diane L Martire; Atul Malhotra
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

8.  Nocturia and disturbed sleep in the elderly.

Authors:  Donald L Bliwise; Daniel J Foley; Michael V Vitiello; Farzaneh Pour Ansari; Sonia Ancoli-Israel; James K Walsh
Journal:  Sleep Med       Date:  2008-08-13       Impact factor: 3.492

9.  Effect of Shift Work on Nocturia.

Authors:  Jin Wook Kim
Journal:  Urology       Date:  2015-09-08       Impact factor: 2.649

10.  Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort.

Authors:  Sairam Parthasarathy; MaryPat Fitzgerald; James L Goodwin; Mark Unruh; Stefano Guerra; Stuart F Quan
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

View more
  15 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

2.  The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.

Authors:  Po-Ming Chow; Shih-Ping Liu; Yao-Chi Chuang; Kyu-Sung Lee; Tag Keun Yoo; Limin Liao; Jian-Ye Wang; Ming Liu; Budiwan Sumarsono; Jar Jar Jong
Journal:  World J Urol       Date:  2018-05-23       Impact factor: 4.226

3.  US Trends in Prevalence of Sleep Problems and Associations with Chronic Kidney Disease and Mortality.

Authors:  Monica Shieu; Hal Morgenstern; Jennifer Bragg-Gresham; Brenda W Gillespie; Q Afifa Shamim-Uzzaman; Delphine Tuot; Sharon Saydah; Deborah Rolka; Nilka Rios Burrows; Neil R Powe; Rajiv Saran
Journal:  Kidney360       Date:  2020-05-01

4.  Canadian Urological Association best practice report: Diagnosis and management of nocturia.

Authors:  Laura N Nguyen; Harkanwal Randhawa; Geneviève Nadeau; Ashley Cox; Duane Hickling; Lysanne Campeau; Juliana Li; Blayne Welk; Kevin Carlson; Greg Bailly; Richard Baverstock; Sender Herschorn
Journal:  Can Urol Assoc J       Date:  2022-07       Impact factor: 2.052

5.  Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment.

Authors:  Youko Ikeda; Irina Zabbarova; Mathijs de Rijk; Anthony Kanai; Amanda Wolf-Johnston; Jeffrey P Weiss; Edwin Jackson; Lori Birder
Journal:  Continence (Amst)       Date:  2022-05-25

6.  Frequent nocturnal urination in older men is associated with arterial stiffness: The Nagahama study.

Authors:  Yasuharu Tabara; Takeshi Matsumoto; Kimihiko Murase; Kazuya Setoh; Takahisa Kawaguchi; Shunsuke Nagashima; Shinji Kosugi; Toyohiro Hirai; Takeo Nakayama; Tomoko Wakamura; Kazuo Chin; Fumihiko Matsuda
Journal:  Hypertens Res       Date:  2019-08-09       Impact factor: 3.872

Review 7.  The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Authors:  Giuseppe Loddo; Giovanna Calandra-Buonaura; Luisa Sambati; Giulia Giannini; Annagrazia Cecere; Pietro Cortelli; Federica Provini
Journal:  Front Neurol       Date:  2017-02-16       Impact factor: 4.003

Review 8.  Pharmacotherapy for Nocturia.

Authors:  Karl-Erik Andersson; Philip Van Kerrebroeck
Journal:  Curr Urol Rep       Date:  2018-02-09       Impact factor: 3.092

Review 9.  Nocturia: consequences, classification, and management.

Authors:  Noam D Fine; Jeffrey P Weiss; Alan J Wein
Journal:  F1000Res       Date:  2017-09-01

10.  Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria.

Authors:  Sangjun Yoo; Juhyun Park; Sung Yong Cho; Min Chul Cho; Hyeon Jeong; Hwancheol Son
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.